Catalyst Wire Dossier Catalyst Wire Dossier

GPO Seasonal Tetravalent Inactivated Split Virion Influenza Vaccine

influenza vaccine, inactivated, split virion, tetravalent · Government Pharmaceutical Organization (GPO)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GPO Seasonal Tetravalent Inactivated Split Virion Influenza Vaccine, covering 2024-10-09 to 2024-10-09. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of GPO Seasonal Tetravalent Inactivated Split Virion Influenza Vaccine in Healthy Thais [Phase 1, Phase 2]

See pricing